DJ Regeneron Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. $(REGN)$ slid 1.00% to $788.04 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.51% to 7,743.41 and the Dow Jones Industrial Average rising 0.93% to 51,828.62.
This was the stock's third consecutive day of losses.
Regeneron Pharmaceuticals Inc. closed 8.30% below its 52-week high of $859.34, which the company reached on September 3rd.
The stock underperformed when compared to some of its competitors Friday, as Amgen Inc. $(AMGN)$ rose 2.11% to $414.61, Moderna Inc. (MRNA) rose 2.08% to $198.88, and Gilead Sciences Inc. (GILD) rose 0.83% to $150.93.
Trading volume (539,727) remained 209,056 below its 50-day average volume of 748,783.
Data source: Dow Jones Market Data, FactSet. Data compiled September 25, 2026.